Top insider buys: Dec 4 – Dec 10, 2023

The largest open-market purchases company insiders reported on SEC Form 4 between Dec 4 – Dec 10, 2023.

Week 49, 2023

#	Company	Who bought	Shares	Value	Source
1	GBIO Generation Bio Co.	3 officers/directors Cluster buy Anthony G. Quinn, Charles A. Rowland Jr., Donald William Nicholson	531,455	$747K	SEC filings
2	HI Hillenbrand, Inc.	2 officers/directors Cluster buy Kimberly K. Ryan, Helen W. Cornell	9,647	$374K	SEC filings
3	EYPT EyePoint Pharmaceuticals, Inc.	10% Owner Cormorant Asset Management, LP	1,919,057	$41.9M	SEC filings
4	NC SLF Inc.	10% Owner Chrysler Retirees Medical Benefits Plan Uaw	2,528,343	$24.8M	SEC filings
5	RANI Rani Therapeutics Holdings, Inc.	10% Owner South Cone Investments Limited Partnership	5,265,165	$10.6M	SEC filings
6	BIGZ BlackRock Innovation & Growth Term Trust	10% Owner Saba Capital Management, L.P.	1,429,704	$10.5M	SEC filings
7	SCVL SHOE CARNIVAL INC	2 separate filers Delores B. Weaver, Wayne J. Weaver	413,000	$10.4M	SEC filings
8	ECAT BlackRock ESG Capital Allocation Term Trust	10% Owner Saba Capital Management, L.P.	619,126	$9.8M	SEC filings
9	BMEZ BlackRock Health Sciences Term Trust	10% Owner Saba Capital Management, L.P.	619,409	$8.7M	SEC filings
10	BCAT BlackRock Capital Allocation Term Trust	10% Owner Saba Capital Management, L.P.	285,566	$4.2M	SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.